Join
Live feed
·
PRReleasevia Quantisnow
Oncocyte Corporation logo

Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine

ByQuantisnow·Wall Street's wire, on your screen.
OCX· Oncocyte Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCX (Oncocyte Corporation) and more on Quantisnow.